Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Elucidating the effect of Connexin-26 on CAR-T cell proliferation from a mechanistic perspective

FY 2023-24

Summary
Cancer is the leading cause of premature death in Canada. Recent advances in immunology have paved the way for novel cancer treatments that harness and train immune cells, such as T cells, to target cancer. T cells normally provide the human body protection by surveilling and eliminating harmful cells, but we can engineer them to be more robust and facilitate increased cancer killing. Currently, to maximize engineered T cell efficacy, scientists are looking for ways to increase the capacity of the T cell to grow and divide into daughter cells, also known as T cell proliferation. The goal is to optimize proliferation before the engineered T cells become dysfunctional, as a result of the harsh tumour environment, to boost overall cancer killing. A recent finding shows that the protein Connexin 26 (Cx26) is involved in T cell proliferation and therefore is an attractive protein to study. Interestingly, Cx26 is primarily found in specialized ear cells and has never before been reported in T cells. We intend to better understand the mechanism of action by which Cx26 activates proliferation in T cells, and to harness this proliferative effect in engineered T cells to determine whether the T cell performance is improved. Ultimately, we seek to tackle the challenges associated with engineered T cell proliferation, to provide optimal treatment in the clinic.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506169
Name
Shiwram Ariya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the effect of Connexin-26 on CAR-T cell proliferation from a mechanistic perspective
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adoptive Cell Transfer; Antitumour Activity; Cell Signalling; Cell Survival And Proliferation; Genetic Engineering; Immunology; Mechanism Of Action; Protein Overexpression; Proteomics; T Cell Activation
Abstract
Cancer is the leading cause of premature death in Canada. Recent advances in immunology have paved the way for novel cancer treatments that harness and train immune cells, such as T cells, to target cancer. T cells normally provide the human body protection by surveilling and eliminating harmful cells, but we can engineer them to be more robust and facilitate increased cancer killing. Currently, to maximize engineered T cell efficacy, scientists are looking for ways to increase the capacity of the T cell to grow and divide into daughter cells, also known as T cell proliferation. The goal is to optimize proliferation before the engineered T cells become dysfunctional, as a result of the harsh tumour environment, to boost overall cancer killing. A recent finding shows that the protein Connexin 26 (Cx26) is involved in T cell proliferation and therefore is an attractive protein to study. Interestingly, Cx26 is primarily found in specialized ear cells and has never before been reported in T cells. We intend to better understand the mechanism of action by which Cx26 activates proliferation in T cells, and to harness this proliferative effect in engineered T cells to determine whether the T cell performance is improved. Ultimately, we seek to tackle the challenges associated with engineered T cell proliferation, to provide optimal treatment in the clinic.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shiwram, Ariya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~